PMID: 3399069Aug 1, 1988Paper

Central pontine myelinolysis in severely burned patients: relationship to serum hyperosmolality

Neurology
A C McKeeB Q Banker

Abstract

The rapid correction or over-correction of hyponatremia is believed by many to be the crucial factor in the causation of central pontine myelinolysis (CPM). Over a 17-year period we found CPM in 10 (7%) of the 139 burn patients examined postmortem but in only 10 (0.28%) of the 3,528 patients in the general autopsy population (p less than 0.001). Each of the burn patients with CPM had suffered a prolonged, nonterminal episode of extreme serum hyperosmolality, whereas most burn patients without CPM had not suffered such an episode. The histologic age of the lesions correlated with the duration of time between the hyperosmolar episode and death. Hypernatremia, hyperglycemia, and azotemia, alone or combined, accounted for the hyperosmolality. No single electrolyte or metabolic derangement was essential, as in at least one burn patient with CPM the serum sodium, glucose, or blood urea nitrogen was normal during the hyperosmolar episode. Hyponatremia was not present in any burn patient with CPM. We conclude that severely burned patients, like alcoholics, are especially susceptible to CPM, and that in burn patients with CPM there is a striking association with serum hyperosmolality. The data also suggest that the rapid correction of h...Continue Reading

Citations

Jan 1, 1996·Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·E F WijdicksR H Wiesner
Jan 1, 1991·Movement Disorders : Official Journal of the Movement Disorder Society·F X TisonJ Julien
May 1, 1992·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·A B Gruskin, A Sarnaik
May 18, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Yoon-Sik JoSang-Jun Na
Oct 1, 1996·Journal of the Neurological Sciences·K L Newell, B K Kleinschmidt-DeMasters
Nov 1, 1995·Clinical Neurology and Neurosurgery·S PradhanV Kher
Jun 1, 1996·Burns : Journal of the International Society for Burn Injuries·G J MukhdomiD N Herndon
Jul 1, 1997·Journal of the Neurological Sciences·B K Kleinschmidt-DeMastersD Rubinstein
Apr 6, 2002·Brain & Development·Takeo KatoKoichi Tanaka
May 24, 2003·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·C ChanT Harrington
Aug 17, 1989·The New England Journal of Medicine·M E CharnessD A Greenberg
May 12, 2006·The Neurologist·Michael N Diringer, Allyson R Zazulia
Aug 2, 2011·Seminars in Dialysis·Jeffrey C Sirota, Tomas Berl
Oct 27, 2001·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·B ValiulisS London
Jan 1, 1994·Journal of Veterinary Internal Medicine·D P O'BrienM J Nelson
Nov 1, 1991·Journal of Clinical Pathology·A P BoonP McMaster
Jul 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·A H HolmesA Edwards
Jun 1, 1993·Journal of Neurology, Neurosurgery, and Psychiatry·C P HarrisJ R Baringer
Aug 28, 2012·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Mohamed Osama Hegazi, Anant Mashankar
Jul 9, 2013·Burns : Journal of the International Society for Burn Injuries·Shiu-Dong ChungJiunn-Horng Kang
Mar 4, 2014·Rinshō shinkeigaku = Clinical neurology·Toshiyuki Sakai, Hidekazu Tomimoto
Feb 21, 2002·Journal of Cardiothoracic and Vascular Anesthesia·Kati Järvelä, Seppo Kaukinen
Apr 7, 1998·The Journal of Trauma·J PneumatikosG Nakos
Nov 10, 2013·The Journal of Emergency Medicine·Azeemuddin AhmedAmy Engelman
Mar 13, 2013·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Waldo R GuerreroStephen E Nadeau
Mar 1, 1990·Kidney International·T Berl
Jan 18, 2006·Journal of Neuropathology and Experimental Neurology·B K Kleinschmidt-DemastersChristopher M Filley
Feb 14, 2012·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Yutaka SuzukiSatoshi Kamei
Sep 30, 2009·Forensic Science International : Synergy·Kana UnumaKen-ichi Yoshida
May 1, 1992·The American Journal of Medicine·R TienJ Kucharczyk
Apr 7, 2005·Diabetes Research and Clinical Practice·Mitsuyo ShintaniHaruo Nishimura
May 1, 1993·The American Journal of Medicine·Barbara Illowsky Karp
Sep 1, 1996·Seminars in Pediatric Neurology·M K GingoldA J Rosas
Jan 1, 1994·Annales Françaises D'anesthèsie Et De Rèanimation·C IchaiD Grimaud
Feb 1, 1992·Burns : Journal of the International Society for Burn Injuries·Y Y LiY Liu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.